Clinical Trial Update: A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer [Phase 1, Phase 2]

View source ↗

Summary

This is an ongoing Phase 1/2 clinical trial evaluating Repotrectinib in combination with chemotherapy for children and young adults with metastatic solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Repotrectinib (repotrectinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Advanced Cancer, Metastatic Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING